These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 15764047

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J.
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I, Cornell RC, Penneys NS, Zaias N.
    Clin Ther; 1986 Sep; 8(3):275-82. PubMed ID: 3521856
    [Abstract] [Full Text] [Related]

  • 8. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
    Griffiths CE, Finlay AY, Fleming CJ, Barker JN, Mizzi F, Arsonnaud S.
    J Dermatolog Treat; 2006 Sep; 17(2):90-5. PubMed ID: 16766333
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
    Sofen H, Hudson CP, Cook-Bolden FE, Preston N, Colón LE, Colón LE, Caveney SW, Gottschalk RW.
    J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
    [Abstract] [Full Text] [Related]

  • 14. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N, Feldman SR, Sherer D, Weiss J, Shavin JS, Lin YL, Foley V, Soto P.
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The evolving role of therapeutic shampoos for targeting symptoms of inflammatory scalp disorders.
    Kircik L.
    J Drugs Dermatol; 2010 Jan; 9(1):41-8. PubMed ID: 20120424
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Class I topical corticosteroid use by psoriasis patients in an academic practice.
    Pearce DJ, Spencer L, Hu J, Balkrishnan R, Fleischer AB, Feldman SR.
    J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.